ABSTRACT Single nucleotide polymorphism (SNP) set tests have been a powerful method in analyzing next-generation sequencing (NGS) data. The popular sequence kernel association test (SKAT) method tests a set of variants as random effects in the linear mixed model setting. Its P-value is calculated based on asymptotic theory that requires a large sample size. Therefore, it is known that SKAT is conservative and can lose power at small or moderate sample sizes. Given the current cost of sequencing technology, scales of NGS are still limited. In this report, we derive and implement computationally efficient, exact (nonasymptotic) score (eScore), likelihood ratio (eLRT), and restricted likelihood ratio (eRLRT) tests, EXACTVCTEST, that can achieve high power even when sample sizes are small. We perform simulation studies under various genetic scenarios. Our EXACTVCTEST (i.e., eScore, eLRT, eRLRT) exhibits well-controlled type I error. Under the alternative model, eScore P-values are universally smaller than those from SKAT. eLRT and eRLRT demonstrate significantly higher power than eScore, SKAT, and SKAT optimal (SKAT-o) across all scenarios and various samples sizes. We applied these tests to an exome sequencing study. Our findings replicate previous results and shed light on rare variant effects within genes. The software package is implemented in the open source, highperformance technical computing language JULIA, and is freely available at https://github.com/Tao-Hu/VarianceComponentTest.jl. Analysis of each trait in the exome sequencing data set with 399 individuals and 16; 619 genes takes around 1 min on a desktop computer.
a quantitative/binary trait in an unrelated sample (Wu et al. 2011) . It tests a SNP set as random effects using a quadratic form and uses a mixture of chi-squared distributions as its asymptotic null distribution. Compared to burden tests, a linear mixed model (LMM)-based method is more powerful when a genetic region has both protective and deleterious variants or many noncausal variants (Lee et al. 2012) . However, SKAT may still be underpowered at small sample sizes, as it uses an asymptotic score test based on large sample theory. In this article we consider exact variance component tests that are applicable to genetic studies with small to moderate sample sizes.
Testing variance components in the LMM framework is challenging and has received considerable attention in the statistical literature (Chen and Dunson 2003; Kinney and Dunson 2007; Greven et al. 2008; Saville and Herring 2009; Drikvandi et al. 2013; Qu et al. 2013) . Although likelihood ratio test (LRT) and restricted likelihood ratio test (RLRT) are known to be more powerful than score tests in finite samples, they impose serious computational challenges to genome-wide studies, as the alternative model has to be fit for each SNP set and the calculation of P-values is computationally expensive. Previous efforts in genetics studies include Zeng et al. (2014 and .
In summary, our contributions in this work are fourfold. First, we develop the exact score (eScore) test that achieves higher power than SKAT at small sample sizes but maintains computational efficiency. Second, we examine the computational bottleneck of the exact likelihood ratio test (eLRT) and the exact restricted likelihood ratio test (eRLRT) and design new algorithms that are scalable to genomic studies. Third, we investigate the power of three exact variance component tests under various genetic study scenarios and demonstrate that the exact variance component tests have proper type I error rates in small sample sequencing association studies, and that eLRT and eRLRT significantly boost power in rare variant studies. Last, we develop and freely distribute a user-friendly software for genetic testing using the three exact variance component tests.
Methods

Notations and models
Suppose y is an n 3 1 vector of quantitative phenotypes, X is an n 3 p covariate matrix (e.g., gender, smoking history, principal components, etc.), G is an n 3 m genotype matrix of m genetic variants, and W is a prespecified diagonal weight matrix for genetic variants. We consider a standard LMM
where b are fixed effects, g are random genetic effects, and s 2 g and s 2 e are variance component parameters for the SNP set and environmental effects respectively. Therefore, the phenotype vector y has covariance
where S ¼ GWG9 is the kernel matrix capturing effects of the SNP set. The resulting log-likelihood function is 
In the following sections, we present the test statistics for the three exact tests along with their null distributions and then outline the computational strategy to scale them to genome-wide studies. Detailed derivations are delegated to the Supplemental Material, File S1. 
whereb ¼ ðX9XÞ 21 X9y is the least squares estimate of fixed effects and trðMÞ represents the sum of diagonal entries of a square matrix M: The exact score test (eScore) rejects the null hypothesis when S score is large. Let s ¼ rankðXÞ; P X ¼ XðX9XÞ 21 X9 be the projection matrix onto the column space CðXÞ; and fm 1 ; . . . ; m k g be the strictly positive eigenvalues of ðI n 2 P X ÞSðI n 2 P X Þ: Under the null hypothesis s
where w 1 ; . . . ; w n2s are independent standard normals. The P-value of observed S Score ¼ t equals the tail probability are independent chi-square random variables. Therefore eScore P-values can be calculated Top panel shows the cases when simulation region include both common and rare, while bottom panel shows the cases when only rare variants are included.
using the same numerical methods SKAT uses to evaluate the tail probability of a mixture of independent chi-squares. Moreover, whenever the ratio of two quadratic forms in (3) is less than the threshold n 21 trðSÞ; it represents evidence against the alternative hypothesis and the correct P-value should be 1. This saves considerable computation as most test regions are not associated with the trait.
In contrast, SKAT employs the test statistic In this section we first review the eLRT and eRLRT for testing a single variance component proposed by Crainiceanu and Ruppert (2004) , and then discuss the computational challenges for applying them to sequencing studies. Section S.3 in File S1 gives self-contained derivation. The LRT statistic for testing H 0 : s
Under the null model s
where w 1 ; . . . ; w n2s are independent standard normals, j 1 ; . . . ; j ℓ are the strictly positive eigenvalues of S; and fm 1 ; . . . ; m k g are the strictly positive eigenvalues of ðI n 2 P X ÞSðI n 2 P X Þ:
The RLRT is based on the restricted/residual loglikelihood
where I 2 P X ¼ QQ9: The RLRT statistic is
which, under the null model s 2 g ¼ 0; has exact distribution
where w 1 ; . . . ; w n2s are independent standard normals and fm 1 ; . . . ; m k g are the strictly positive eigenvalues of ðI n 2 P X ÞSðI n 2 P X Þ: Applying eLRT and eRLRT to NGS studies, which routinely test 10 3 10 6 genes or SNP sets, incurs serious computational challenges. First we need to find the MLE ðb;ŝ e Þ for each SNP set, which requires repeatedly inverting n 3 n matrices, an expensive operation when n is large. Second, computing the P-value of eLRT or eRLRT for each SNP set is nontrivial. Crainiceanu and Ruppert (2004) propose the straightforward way of simulating B points from the null distribution (6) or (9). That involves solving B univariate optimizations, where B needs to be at order of 10 6 to obtain P-values at order of 10 24 with accuracy. This method is hard to scale to genomic scans with a large number of SNP sets.
Implementation
We attack the first computational challenges by an efficient and stable algorithm for fitting the alternative model that avoids repeatedly inverting matrices. We resolve the second challenge by using an accurate approximation that only requires simulating a small number of points from the null distributions.
Fast algorithm for fitting variance component model
This section describes an efficient algorithm for fitting the variance component Model 2 or restricted-likelihood Model 7. Let S ¼ Udiagðj 1 ; . . . ; j n ÞU9 be the eigen decomposition of the SNP set variance matrix. Then 
which can be maximized by a minorization-maximization (MM) technique (Hunter and Lange 2000) . The simple MM updates are
See section S.4 in File S1 for the derivation of the MM updates. This algorithm avoids repeatedly inverting n 3 n matrices as only one eigen decomposition is required. Each iteration only involves solving a weighted least squares problem and OðnÞ operations for updating variance components. This algorithm is numerical stable as each update of b and ðs
e Þ always increases the log-likelihood value. For eRLRT, we need to find the REML for each SNP set. Let B 2 ℝ n 3 ðn2sÞ be an orthonormal basis of CðXÞ t ; e.g., obtained from the singular value decomposition of X: Then B9Y is multivariate normal with mean 0 n2s and covariance
Let the eigen decomposition of the covariance matrix B9SB be
Then the transformed dataỸ ¼ G9B9Y has independent components
. . . ; j n2s Þ Á and the restricted log-likelihood function (7) becomes 2 n 2 s 2 lnð2pÞ 2 1 2
It becomes clear that the MM updates (10) remain unchanged for finding REML except replacing r i byỹ i and n by n 2 s:
Approximating null distributions of eLRT and eRLRT
Calculation of eLRT and eRLRT P-values relies on drawing samples from the theoretical null distributions (6) and (9). Typical genome scans test 10 3 10 5 SNP sets. An exomewide significant P-value at a level of 10 26 requires drawing about 10 7 samples from the null distribution and each of them requires solving a univariate optimization problem. Hence the P-value calculation for eLRT and eRLRT is computationally intensive. We propose an approximation scheme that only requires drawing a small number of samples for each SNP set and thus is highly scalable to genomic scans.
We approximate the exact null distributions (6) and (9) by a mixture distribution of form p 0 x 2 0 : ð1 2 p 0 Þax 2 b ; where the point mass p 0 at 0, scale parameter a, and the degree of freedom b for the chi-squared distribution need to be determined for each SNP set. We illustrate with eLRT. Denote the expression to be maximized in (6) by f ðlÞ: The point mass of the null distribution at 0 is well approximated by the probability of f ðlÞ having a local maximum at 0
Therefore p 0 is calculated by either numerically evaluating the cumulative distribution function of the mixture of chisquare distribution at 0 or by the simple Monte Carlo method.
To approximate the continuous part ax 2 b of null distribution, we simulate a small number (300 by default) of S LRT by numerically maximizing f ðlÞ using the Newton-Raphson method, and then estimate parameters a and b by matching the first two sample moments to those of ax 2 b : This approximation scheme is well known as the Satterthwaite method in statistics (Satterthwaite 1941) , which has been used successfully to approximate the null distributions of many test statistics. The performance of our approximation is included in the section S.5 in File S1, which indicates that our approximation method works well for generating P-values and reducing computational burden.
Data availability
Simulated data sets are generated using computing language JULIA and are available upon request. COPDGene exome sequencing study (http://www.copdgene.org/) is part of the National Heart, Lung, and Blood Institute (NHLBI) Grand Opportunity Exome Sequencing Project (GO-ESP) and has been deposited to database of Genotypes and Phenotypes (dbGaP) (study accession: phs000296.v3.p2).
Results
We first illustrate the subtle differences between SKAT and eScore for the motivation of exact tests. We then conduct a comprehensive simulation study to illustrate the control of type I error rate and the power under various conditions of genetic association. These simulations were designed to evaluate two primary questions: (1) e is a biased estimate and the SKAT P-values are systematically larger than those from eScore, especially in the region of small P-values. This can lead to loss of power by SKAT in genome scans where a stringent P-value threshold is necessary to correct multiple testing. The difference is more dramatic at smaller sample sizes or stronger effect size s 2 g : For both type I error and power simulation studies, we use the haplotype pool that comes with the SKAT software (Wu et al. 2011) to generate genotypes of study samples. That is, for each simulation replicate, we pair 2n randomly drawn haplotypes to form the genotypes of a sample of n subjects. To assess empirical type I error of eScore, eLRT, and eRLRT, we consider combinations of following factors:
1. test region: first 5 or 10 kb, 2. samples size n: 500, 1000, or 2000, and 3. significance level a: 0.05, 0.01, or 0.0001.
The average number of variants are 97 and 193 for 5-and 10-kb regions, respectively. We evaluate type I error when both common and rare variants are included in the region as well as when only rare variants (MAF ,5%) are included in the region. We generate 10 6 replicates for each simulation scenario. For each replicate, we first simulate four continuous covariates from independent standard normals, one binary covariate from Bernoulli(0.5), and then generate phenotypes from Model 1 with b ¼ 1; s Table 1 show that the three exact tests control type I error at all a levels.
For power comparisons, we take the first 10 kb of the haplotype pool as the test region. Over simulation replicates, testing regions include around 193 variants and 80-150 observed variants on average (Table 2 ). Average proportion of rare variants (MAF ,0.05) are 80.8, 84.3, and 87.9% for sample sizes of 500, 1000, and 2000, respectively. The number of causal variants for different models are also shown in Table 2 . This is among the settings where we have evaluated protected type I error. Covariates are generated in the same manner as in the last section and we set fixed effects at b ¼ 1: For Models 1 and 4, causal effects g follow a normal distribution Nð0; s 2 g IÞ: Models 2, 3, 5, and 6 mimic the simulation schemes in Wu et al. (2010) , where the magnitude of causal effects g is determined by cjlogðMAFÞj; so that rarer variants have larger effects. In Wu et al.'s (2010) article, c was set up as 0.4 and in Lee et al.'s (2014) article c was set as 0.14, which provides 80% power at level a , 10 28 when the sample size is 50,000. In our simulations, we chose s 2 g and c by fixing heritability h 2 ; where h 2 ¼ VarðGgÞ=VarðYÞ; so that power is in the comparable ranges for most of methods given sample sizes. Environmental variance s 2 e was fixed at 1. For Models 1 and 4, we chose s 2 g to be, As a comparison we list the mean and standard deviation of our simulated c over simulation replicated in File S1 (Table S1 ). It is shown that our c is smaller compared to Wu et al. (2010) and Lee et al. (2014) , which indicates smaller heritability explained by testing regions. We consider the following simulation factors to evaluate power and label them as Models 1-6 in Table 3: 1. sample size n: 500, 1000, or 2000, 2. heritability h 2 : 5 or 10%, 3. MAF of causal variants: common and rare (MAF ,0.5) or rare only (MAF ,0.05), 4. percentage of causal variants: 10 or 30%, 5. distribution of causal effects: Nð0; s 2 g Þ or cjlogðMAFÞj; 6. direction of causal effects: half positive and half negative or all positive.
Significant level a is 10 24 : We simulate 1000 replicates for each scenario. Therefore the largest Monte Carlo standard error for power estimate is controlled below ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi 0:5 3 ð1 2 0:5Þ=1000 p 0:016: For simplicity, in both simulation and real data analysis, SNP weights are not incorporated and the linear kernel is adopted for both exact tests and SKAT. SKAT optimal (SKAT-o) uses the default setting in Lee et al. (2012) . Note all exact tests can incorporate variant weights or other kernels just as in SKAT or SKAT-o. Figure 2 displays the results for Models 1, 2, and 3 (common and rare causal variants) and Figure 3 for Models 4, 5, and 6 (rare causal variants only). Left panels of both figures are the results when 10% of the variants in the region are causal, while the right panels show powers when 30% of variants are causal. It is clear that (1) performance of score tests (SKAT and eScore) are comparable in these scenarios; (2) eLRT and eRLRT significantly boosts power over score tests across all scenarios, especially when causal variants are rare only or sample size is small; and (3) when the causal variants are both common and rare, the SKAT-o method can increase power extensively compared with SKAT method with linear kernel. Its power is comparable to eLRT and eRLRT (Figure 2 ).
COPDGene exome sequencing study
We further illustrate our methods using the COPDGene exome sequencing study (http://www.copdgene.org/). It is part of Genes that pass Bonferroni corrected genome-wide significance level of 3 3 10 26 are in boldface font. Position is the base pair position in the middle of the gene. Chr, chromosome of the test region; SetSize, the number of SNPs in the test region. ** P , 3 3 10 26 , * P , 10 24 . NHLBI GO-ESP project (dbGaP study accession: phs000296. v3.p2). After quality control, 399 individuals remain for the analysis (Qiao et al. 2016) . We analyze 16; 619 genes along the genome and apply different testing methods to three phenotypes: height, cigarette packages per year (PackYears), and body mass index (BMI). Table S2 in File S1 tabulates their descriptive statistics. For all three phenotypes, we adjust population substructure using the top three eigenvectors generated by the Eigenstrat software (Price et al. 2006) , age, and gender. For PackYears, we additionally adjust for current smoking status. Table 4 shows the numbers of gene sets that pass Bonferroniadjusted exome-wide significance level 3 3 10 26 : Table 5 contains detailed information of gene sets that pass exomewide significance level for height. It also lists gene sets with P-value , 10 24 for trait PackYears and BMI for the purpose of side-by-side comparison of P-values, as none of the gene sets pass the exome-wide significant level.
We make following observations: (1) For the complex trait height, eLRT and eRLRT identify 8 and 15 genes that pass the Bonferroni-adjusted, genome-wide significant level and eScore identifies 5. In contrast, SKAT and SKAT-o only identify four and three respectively. (2) For the other two traits, no genes pass Bonferroni-adjusted genome-wide significance level in all tests. (3) eScore P-values are universally smaller than SKAT. This agrees with the simulation results in Figure 1 that the asymptotic test by SKAT can lose power at small samples size and strong signals. (4) The optimal kernel in SKAT-o does not show advantage over SKAT with linear kernel and no weight in this analysis ( Figure S1 ).
Computational efficiency of ExactVC
We compare the computational time of different methods. Table 6 records the run times of each method on a desktop with i7-3770 central processing unit of 3.40 GHz and 16 GB RAM. For each trait, exact tests (eScore and eRLRT) complete the analysis in ,1 min, while eLRT uses around a minute. SKAT takes slightly longer than eScore, while SKAT-o takes significantly longer than all of the tests. Note that although LRT and RLRT is considered more computationally intensive compared to the score test, Table 6 shows that the speed of our eLRT test is comparable to eScore and SKAT tests, while eRLRT is even faster.
Discussion
In this report we study and implement computationally efficient exact variance component tests (eScore, eLRT, and eRLRT) for testing SNP sets in sequencing studies. Simulation study and real data analysis show that (1) all exact tests control type I error, (2) eScore yields smaller P-values than SKAT at small sample size and strong signal, and (3) eLRT and eRLRT significantly boost power over eScore, SKAT, and SKAT-o, especially when sample size is small or there are plenty of rare variants. By supplying a fast and easy-to-use software package, we hope to boost the power and efficiency of gene mapping based on current NGS technology. Although the derivation of eLRT and eRLRT require normal assumption of genetic effects within a region, we evaluate the misspecified distribution and how that will affect power. In all scenarios, even without normal assumption, our methods show superior power compared with competing methods. The software package, EXACTVCTEST, is implemented in the open source, high-performance technical computing language JULIA and is freely available at https://github.com/Tao-Hu/ VarianceComponentTest.jl.
There are a few directions for future work. One advantage of the asymptotic test by SKAT is that it does not depend on the normality assumption and equally applies to association testing of binary traits (Wu et al. 2011; Lee et al. 2012) , while the exact tests depend on the normality assumption. Fortunately many quantitative traits satisfies the normality assumption after suitable transformations. Development of LRT and RLRT for binary trait remains a challenge. Another statistical challenge is to develop LRT or RLRT for testing SNP set in related samples. An asymptotic score test has been developed by Chen et al. (2013) . Rigorous testing of multiple variance components still remains a statistical challenge (Crainiceanu 2008; Drikvandi et al. 2013) . Figure S1: Pvalues comparisons with and without 2 approximation for sample size 500, 1000, and 2000. Pvalues from eLRT tests are shown in columns one and two, while pvalues from eRLRT are shown in columns three and four. Second and forth columns are the zoom-in plots when pvalues are less than one. 1000 simulation replicates are included. Phenotypes are simulated under the null hypothesis and 10kb testing region is used for evaluation (e.g., scenario (2) in Table 3 Table S2 : Descriptive statistics of 3 phenotypes in COPDGene exome sequencing study.
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S.1 Model and notations
Suppose y is a n × 1 vector of quantitative phenotype, X is an n × p covariate matrix (e.g., grand mean, sex, smoking history, height, principal components, etc), β is a p × 1 vector of fixed effects, G is an n × m genotype matrix for m genetic variants, γ is their effects and follows an normal distribution with variance σ 2 g W . W is the prespecified diagonal weight matrix for the rare variants of size m × m. ε is the usual normal distributed random errors with mean zero and covariance σ 2 e I n . We consider a standard linear mixed model y = Xβ + Gγ + ε, γ ∼ N (0 m , σ 2 g W ), and ε ∼ N (0 n , σ 2 e I n ) where σ 2 g and σ 2 e are corresponding variance component parameters for the SNP set and environmental effects. Therefore, Var(y) = V = σ 2 g S + σ 2 e I n , where S = GW G is the kernel matrix capturing effects from the SNP set.
Throughout the paper, we let P X = X(X X) −1 X be the projection matrix onto the column space of C(X), I n − P X be the projection matrix onto the complimentary null space of N (X ) = C(X) ⊥ . Let {ξ 1 , . . . , ξ } be the positive eigenvalues of S and {µ 1 , . . . , µ k } be the positive eigenvalues of (I − P X )S(I − P X ). We denote l = rank(S), k = rank((I − P X )S(I − P X )) and s = rank(X) and define Q 0 ∈ R n×s be an orthonormal basis of C(X), Q 1 ∈ R n×k be an orthonormal basis from the eigendecomposition of matrix (I − P X )S(I − P X ), Q 2 ∈ R n×(n−s−k) is an orthonormal basis of C(Q 0 , Q 1 ) ⊥ = C(X, Q 1 ) ⊥ , and Q = (Q 1 , Q 2 ) ∈ R n×(n−s) be an orthonormal basis of the space C(X) ⊥ .
S.2 Derivation of eScore test statistic and null distribution
We derive the exact score test for H 0 : σ 2 g = 0 vs H A : σ 2 g > 0 in the variance component model Y ∼ N n (Xb, V ), where
The log-likelihood function is
and its partial derivative with respect to σ 2 1 is
The information matrix relevant to variance components has entries
Rao's score statistic is based on
evaluated at the MLE under the null. We evaluate the partial derivatives at the MLE under the nullb
That is
from which we form the score statistic
Equivalently the score test rejects when
To derive the null distribution of T , let s = rank(X), the eigen-decomposition of (I −P X )S(I − P X ) be
where k = rank((I − P X )S(I − P X )), Q 2 be an orthonormal basis of C(X, Q 1 ) ⊥ , and Q = (Q 1 , Q 2 ) ∈ R n×(n−s) . Then under the null
where w i are n − s independent standard normals. Here equation (1) is due to the following result.
Proof. Note Q = (Q 1 , Q 2 ) is an orthonormal basis of C(X) ⊥ = N (X ). Therefore QQ is an orthogonal projection matrix onto N (X ). I − P X is also an orthogonal projection matrix onto N (X ). Since orthogonal projection onto a vector space is unique, the equality follows.
Equation (2) is because, under the null, Q y ∼ N (Q Xb, σ 2 e Q IQ) = N (0, σ 2 e I n−s ).
S.3 Derivation of eLRT and eRLRT and their null distributions
Under the same model, we derive exact LRT (eLRT) and exact RLRT (eRLRT) for testing σ 2 g = 0 when V = σ 2 g S + σ 2 e I n (Crainiceanu and Ruppert, 2004) . Let λ = σ 2 g /σ 2 e be the signal-to-noise ratio, and rewrite the covariance as V = σ 2 e (I n + λS) = σ 2 e V λ , where
where
λ . The restricted/residual likelihood ratio test (RLRT) is based on the restricted/residual log-likelihood RL(σ 2 e , λ) = − n−s
Since both I − P X and QQ are the orthogonal projection onto C(X) ⊥ , I − P X = QQ . LRT statistic (3) becomes
It is easy to show that under the alternative model when λ > 0, σ −1 e Q y ∼ N (0 n−s , diag(1 + λµ 1 , . . . , 1 + λµ k , 1, . . . , 1)). Therefore the first term of LRT statistics (3) can be expressed in distribution as sum of squared standard normal distributions. Following the same idea, we can show A λ = QDQ , where D = diag((1 + µ 1 ) −1 , . . . , (1 + µ k ) −1 , 1, . . . , 1). LRT statistics (3) is further reduced to LRT = sup λ≥0 n ln y QQ y − n ln y QDQ y − ln det(V λ ) .
Finally the calculation of LRT statistics becomes an optimization problem with the constraint λ > 0 and Newton-Raphson algorithm is implemented.
Similar derivation as eLRT shows that the null distribution of eRLRT is
where w 1 , . . . , w n−s are normal random variables with covariance diag(1+λξ 1 , . . . , 1+λξ k , 1, . . . , 1).
S.4 Fast algorithm for fitting variance component model
This section is dedicated to a computational algorithm for parameter estimation in a linear mixed effect models with a single variance component (as shown in the manuscript: model (1)). We return to the original parameterization σ 2 e and σ 2 g , then the log-likelihood function is
Our strategy is to update the mean components β and variance components (σ 2 e , σ 2 g ) alternately. Updating β given (σ 2 e , σ 2 g ) is a standard weighted least squares problem. To update (σ 2 e , σ 2 g ) given β, we denote the residuals by r =ỹ −Xβ. The objective is then − 1 2
, which can be maximized by the minorization-maximization (MM) algorithm (Hunter and Lange, 2004) . The MM updates are
Next we consider REML. Let B ∈ R n×(n−s) be an orthonormal basis of C(X) ⊥ , e.g., obtained from the SVD of X. Then B Y is multivariate normal with mean 0 n−s and covariance
Let the eigen-decomposition of the covariance matrix B SB be
Then the transformed dataỸ = Γ B Y has independent components Y ∼ N n−s (0, σ 2 e I n−s + σ 2 g diag(ξ 1 , . . . , ξ n−s )) and the log-likelihood function is
It now becomes clear that the MM updates (5) remain unchanged except replacing r i byỹ i and n by n − s.
S.5 Approximating null distributions of eLRT and eRLRT
We evaluate the performance of our approximation for eLRT and eRLRT using simulations. Scatter plots of pvalues from approximation method against no approximation are shown in Figure 1 . Phenotypes are simulated under the null hypothesis with fixed covariates (e.g. scenario (2) in Table 3 of the manuscript). We also provide zoom-in plots excluding the cases whose pvalues are equal to one. Across 1000 simulation replicates, for eLRT and for sample size 500, 1000, and 2000, the absolute differences range from 1.03 × 10 −4 to 4.07 × 10 −2 , 1.72 × 10 −4 to 3.74 × 10 −2 , and 1.14 × 10 −5 to 4.47 × 10 −2 , respectively. Mean of the absolute differences is around 1.2 × 10 −3 for all three sample size cases while standard deviation is around 4 × 10 −3 . There are 10% among 1000 replicates approximation method generate conservative pvalues than no approximation, while 5% approximation method generate smaller pvalues than no approximation method. For eRLRT, the absolute differences range from 1.01×10 −5 to 3.59×10 −2 , 2.97×10 −5 to 4.48×10 −2 , and 2.26×10 −5 to 3.56 × 10 −2 , for sample size 500, 1000, and 2000 respectively. Mean of the absolute differences for eRLRT is around 3 × 10 −3 for all three sample sizes while standard deviation is 5 × 10 −3 . This simulation indicates that our approximation method works well for generating pvalues and reducing computation burden.
S.6 Simulation
Simulation constant c average over simulation replicates for different models (Table 1) .
S.7 Analysis of COPDGene exome sequencing data
Descriptive statistics of the 3 traits being analyzed (Table 2) . from eLRT tests are shown in columns one and two, while pvalues from eRLRT are shown in columns three and four. Second and forth columns are the zoom-in plots when pvalues are less than one. 1000 simulation replicates are included. Phenotypes are simulated under the null hypothesis and 10kb testing region is used for evaluation (e.g., scenario (2) in Table 3 of the manuscript). Red line represents the line with slope 1 and intercept 0.
